In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...
It has been about a month since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have added about 6.5% in that time frame, outperforming the S&P 500. But investors have to be ...
2026 Maine Senate - Collins vs. Platner Pan Atlantic Platner 43, Collins 42 Platner +1 2026 Maine Senate - Collins vs. Mills Pan Atlantic Collins 43, Mills 43 Tie 2026 California Governor - Open ...
THE first edition of this admirable and well-known treatise was the single-handed work of Prof. Whittaker, and was published in 1902. Into the second edition, which was published thirteen years later ...
Analyzing stochastic cell-to-cell variability can potentially reveal causal interactions in gene regulatory networks.
Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. David Kindness is a Certified Public Accountant (CPA) and an expert in the ...
Thomas, Kyle A., Julian De Freitas, Peter DiScioli, and Steven Pinker. "Recursive Mentalizing and Common Knowledge in the Bystander Effect." Journal of Experimental Psychology: General 145, no. 5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback